Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion type Assertion NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_head.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion description "[In conclusion, miR-195 and miR-378 are abnormally expressed and epigenetically regulated in gastric cancer cell lines and tissues via the suppression of CDK6 and VEGF signaling, suggesting that miR-195 and miR-378 have tumor suppressor properties in gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_provenance.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion evidence source_evidence_literature NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_provenance.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion SIO_000772 23333942 NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_provenance.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion wasDerivedFrom befree-20140225 NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_provenance.
- NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_assertion wasGeneratedBy ECO_0000203 NP816840.RACvrh8X8CuyGmoufF18R26HrxGaoOGH3uQ-YRR-TPNlo130_provenance.